[Policy Recommendations] Requests for the FY2022 Revision of the Medical Service Fee Schedule for the Control of Antimicrobial Resistance (October 12, 2021)
date : 10/13/2021
Tags: AMR
![[Policy Recommendations] Requests for the FY2022 Revision of the Medical Service Fee Schedule for the Control of Antimicrobial Resistance (October 12, 2021)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-27-top_ENG.jpg)
Tokyo, October 12th, 2021 – AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) released requests for the FY2022 Revision of the Medical Service Fee Schedule for the Control of Antimicrobial Resistance. A summary of the requests is as follows.
Over time, bacterium that cause infectious diseases grow immune to the drugs used to treat them. This naturally occurring process is called “antimicrobial resistance” (AMR). This problem can lead to deaths due to infectious diseases that were otherwise preventable. Globally, at least 700,000 people die annually from AMR. If current global trends continue, an estimated 10 million people could die of AMR-related causes every year by 2050. To counter AMR, measures are now advancing around the world. Furthermore, in Japan, approximately 8,000 people already die every year from AMR-related causes, which is more than twice of traffic accidents. Given that Japan’s faces an aging population and globalization, the impact of AMR is likely to grow. To address this issue, we request the current medical service fee schedule be revised to reflect the recommendations described below.
- The revised schedule should facilitate consultations with specialists in infectious disease control.
- The revised schedule should support the placement of infectious disease specialists at university and core hospitals.
- The revised schedule should expand patient eligibility for the premium to support pediatric antimicrobial stewardship measures.
- The revised schedule should facilitate proactive screening for AMR bacteria.
- The revised schedule should enable rapid bacterial culture identification testing.
- The revised schedule should enable rapid antimicrobial susceptibility testing.
- The revised schedule should cover therapeutic drug monitoring during outpatient treatment with voriconazole.
- The revised schedule should facilitate AMR gene detection.
Please see below the PDF file for details.
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)